Literatur
-
1
AACE .
Osteoporosis
Guidelines.
Endocr Pract.
2001;
7
293-312
-
2
Chimeh F, Holick M F.
Novel
use for PTH (1 - 34): An effective safe topical
therapy for treating psoriasis.
J Bone Miner Res (Abstract
F 460).
2000;
11
S
232,
(Suppl 1))
-
3
Herwitz M, Stewart A, Greenspan S L.
Sequential
parathyroid hormone/alendronate therapy for osteoporosis-robbing
Peter for Paul?.
J Clin Endocrinol Metab.
2000;
85
2127-2128
-
4
Herzfeld E, Frieder A.
Beitrag zur Kenntnis
der Epithelkörperwirkung.
Klin Wo.
1932;
30
1262-1263
-
5
Neer R M, Arnaud C D, Zanchetta J R, Prince R, Gaich G A, Reginster J Y, Hodsman A B, Eriksen E F, Ish-Shalom S, Genant H K. et al .
Effect of
Parathyroid Hormone (1 - 34) on fractures
and bone mineral density in postmenopausal women with osteoporosis.
N
Engl J Med.
2001;
344
1434-1441
-
6
Morley P, Whitfield J F, Willick G E.
Parathyroid
Hormone: An Anabolic Treatment for Osteoporosis.
Curr
Pharmaceut Design.
2001;
7
671-687
-
7
Reeve J, Hesp R, Williams D, Hulme P, Klenerman L, Zanelli J M, Darby A J, Tregeaar G W, Parsons J A.
Anabolic effect
of low doses of a fragment of human paratyroid hormone on the skeleton
in postmenopausal osteoporosis.
Lancet.
1976;
1
1035-1036
-
8
Reeve J, Teregear G W, Parsons J A.
Preliminary
trial of low doses of human parathyroid hormone fragment 1 - 34
in treatment of osteoporosis.
Clin Endocrinol.
1976;
21
469-477
-
9
Richter W, Herzfeld E.
Über Epithelkörperchen-Therapie
in der Dermatologie.
Münch Med Wochenschr.
1932;
41
1650-1651
-
10
Rittmaster R S, Bolognese M, Ettinger M P, Hanley D A, Hodsman A B, Kendler D L, Rosen C J.
Enhancement
of bone mass in osteoporotic women with parathyroid hormone followed
by alendronate.
J Clin Endocrinol Metab.
2000;
85
2129-2134
-
11
Seyle H.
On
the stimulation of new bone formation with parathyroid extract and
irradiated ergosterol.
Endocrinology.
1932;
16
547-558
-
12
Tam C S, Heersche J N, Murray T M, Pearsons J A.
Parathyroid
hormone stimulates the bone apposition rate independently of its
resorptive action: differential effects of intermittent and continuous administration.
Endocrinology.
1982;
110
506-512
-
13
Walter D.
The
induction of osteopetroic changes in hypophysiectomized, thyreoparathyroidectomized
and intact rats of various ages.
Endocrinology.
1997;
138
2449-2457
-
14
Whitfield J F, Morley P, Willick G E.
The
parathyroid hormone, its fragments and analogues- potent bone-builders
for treating osteoporosis.
Exp Opin Invest Drugs.
2000;
9
1293-1315
Korrespondenz
Dr. med. Andreas H. Leischker
St Bonifatius Hospital, Abteilung Innere Medizin, Fachbereich
Geriatrie und Abteilung für Physikalische Therapie
Wilhelmstraße 13
49808 Lingen (Ems)
Phone: 0591/9101501
Fax: 0591/9101612
Email: LEISCHKER@AOL.COM
